Percutaneous radiofrequency ablation for hepatocellular carcinoma
@article{Tateishi2005PercutaneousRA, title={Percutaneous radiofrequency ablation for hepatocellular carcinoma}, author={Ryosuke Tateishi and Shuichiro Shiina and Takuma Teratani and Shuntaro Obi and Shin'pei Sato and Yukihiro Koike and Tomonori Fujishima and Haruhiko Yoshida and Takao Kawabe and Masao Omata}, journal={Cancer}, year={2005}, volume={103} }
Radiofrequency ablation (RFA) was introduced recently as a therapeutic modality for hepatocellular carcinoma (HCC), an alternative to percutaneous ethanol injection therapy (PEIT), which is coming into use worldwide. Previously reported treatment efficacy and complication rates have varied considerably.
688 Citations
Comparative study of percutaneous radiofrequency ablation and hepatic resection for small, poorly differentiated hepatocellular carcinomas
- Medicine, BiologyHepatology research : the official journal of the Japan Society of Hepatology
- 2014
Evaluated the relative efficacy and safety of hepatic resection or radiofrequency ablation for treating poorly differentiated hepatocellular carcinomas.
Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma
- Medicine, BiologyHepatology research : the official journal of the Japan Society of Hepatology
- 2016
The efficacy of adding radiofrequency ablation to TACE in patients with intermediate HCC was evaluated, and the factors that were associated with favorable survival in these patients were identified.
Percutaneous tumor ablation for hepatocellular carcinoma.
- MedicineAJR. American journal of roentgenology
- 2011
HCC is increasing in incidence and multiple percutaneous ablation methods are now available for primary treatment or for bridging to transplantation.
Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas
- Medicine, BiologyJournal of gastroenterology and hepatology
- 2009
This study evaluated the therapeutic efficacy and safety of radiofrequency ablation and percutaneous microwave coagulation therapy for the treatment of small HCC measuring ≤ 2 cm in diameter.
Limitation of repeated radiofrequency ablation in hepatocellular carcinoma: Proposal of a three (times) × 3 (years) index
- Medicine, BiologyJournal of gastroenterology and hepatology
- 2012
This work investigated the controllability of HCC and explored the algorithm of therapeutic strategy for HCC in patients who met the RFA criteria.
Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients
- Medicine, BiologyHepatology research : the official journal of the Japan Society of Hepatology
- 2010
This study evaluated the efficacy and safety of radiofrequency ablation (RFA) therapy in elderly patients with hepatocellular carcinoma (HCC) and found it to be safe and effective.
Percutaneous radiofrequency ablation of hepatocellular adenoma: Initial experience in 10 patients
- MedicineJournal of gastroenterology and hepatology
- 2008
The objective of this study was to assess the therapeutic efficacy and safety of percutaneous radiofrequency ablation for hepatocellular adenoma and to establish a protocol for evaluating the safety and effectiveness of this procedure in patients with liver cancer.
Combined transcatheter arterial chemoembolization and radiofrequency ablation in single‐session for solitary hepatocellular carcinoma larger than 7 cm
- MedicineAsia-Pacific journal of clinical oncology
- 2018
To evaluate technical feasibility and treatment results of combined transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) in single‐session for solitary hepatocellular…
Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients
- MedicineANZ journal of surgery
- 2010
The objective of this article to report the experience in a tertiary referral hospital of radiofrequency ablation as either first line or in combination with other treatment modality for patients with HCC.
References
SHOWING 1-10 OF 52 REFERENCES
Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection
- Medicine, BiologyCancer
- 1996
Percutaneous ethanol injection (PEI) therapy is now widely used for small hepatocellular carcinomas (HCC). However, only limited information is available regarding local tumor recurrence after PEI…
Complications of radiofrequency coagulation of liver tumours
- MedicineThe British journal of surgery
- 2002
The purpose of this study was to assess critically the complication rates of RFC in centres with both large and limited initial experience, and to establish causes and possible means of prevention and treatment.
Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases
- MedicineCancer
- 1994
Transcatheter arterial embolization has been used to treat hepatocellular carcinoma (HCC), yet much is still unknown regarding its optimal use.
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma
- MedicineHepatology
- 2001
Radiofrequency ablation with cooled‐tip needle for HCC is associated with a high risk of neoplastic seeding, and has to be considered when selecting curative treatments for H CC or adjuvant therapies before liver transplantation.
Radiofrequency Ablation of Hepatocellular Cancer in 110 Patients With Cirrhosis
- MedicineAnnals of surgery
- 2000
In patients with cirrhosis and HCC, RFA produces effective local control of disease in a significant proportion of patients and can be performed safely with minimal complications.
Nonsurgical Treatment of Hepatocellular Carcinoma: From Percutaneous Ethanol Injection Therapy and Percutaneous Microwave Coagulation Therapy to Radiofrequency Ablation
- MedicineOncology
- 2002
By virtue of their local curability, minimal effect on liver function, and easy repeatability for recurrence, image-guided percutaneous tumor ablations, especially RFA, will be increasingly important in the treatment of HCC.
Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma.
- MedicineUltraschall in der Medizin
- 1999
Percutaneous RF thermal ablation performed after TAE effectively treated HCCs larger than tumors suitable for segmental TAE or RF application alone; the result was achieved in two thirds of the cases in a single session with only one needle electrode insertion.
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.
- MedicineAnnals of surgery
- 1999
RFA is a safe, well-tolerated, and effective treatment to achieve tumor destruction in patients with unresectable hepatic malignancies and multimodality treatment approaches that include RFA should be investigated.
Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply.
- MedicineRadiology
- 2000
Evaluated percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma (HCC) after occlusion of the tumor arterial supply demonstrated a nonenhancing area corresponding in shape to the previously identified HCC, which was suggestive of complete necrosis.
Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection.
- MedicineRadiology
- 1999
RF ablation results in a higher rate of complete necrosis and requires fewer treatment sessions than percutaneous ethanol injection, however, the complication rate is higher with RF ablation than with percutaneously ethanol injection.